BioMerieux SA (OTCMKTS:BMXMF) shares reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as $94.65 and last traded at $94.65, with a volume of 1 shares changing hands. The stock had previously closed at $90.00.
Separately, Zacks Investment Research upgraded BioMerieux from a “sell” rating to a “hold” rating in a report on Tuesday, December 24th.
The stock has a fifty day moving average price of $90.23 and a 200-day moving average price of $83.87.
bioMérieux SA provides vitro diagnostic solutions systems for private and hospital laboratories, primarily for the diagnosis of infectious diseases. The company offers microbiology technology that involves culturing biological samples; and immunoassays technology based on antigen-antibody reaction, detects and measures infectious agents, such as bacteria, viruses, and parasites, as well as measures the specific biomarkers of various pathologies, such as metabolic, hormonal, infectious, etc.
Further Reading: What is the Dividend Aristocrat Index?
Receive News & Ratings for BioMerieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioMerieux and related companies with MarketBeat.com's FREE daily email newsletter.